Transforming allogeneic cell therapy for patients with blood cancer, genetic diseases and autoimmune disorders
Location: United States, California, Sacramento
Employees: 51-200
Total raised: $300M
Founded date: 2016
Investors 6
Date | Name | Website |
- | ND CAPITAL | nd.capital |
- | Lightspeed... | lsvp.com |
- | DCVC | dcvc.com/ |
- | 8VC | 8vc.com |
31.10.2020 | Felicis Ve... | felicis.co... |
- | StartX | startx.com |
Funding Rounds 1
Date | Series | Amount | Investors |
17.06.2020 | Series D | $300M | - |
Persons 1
Date | First Name | Last Name | Title | |||
- | Steve | O'Hara | Investor | linkedin.c... | - | - |
Mentions in press and media 6
Date | Title | Description | Source |
08.09.2022 | Orca Bio looks to increase its cell therapy manufactu... | While Orca Bio has netted some major milestones, such as a $192 million Series D and a regen... | endpts.com... |
08.09.2022 | Manufacturing roundup: Catalent expands in Singapore... | Catalent is looking to expand its clinical supply facility in Singapore. The $2.2 milli... | endpts.com... |
21.12.2021 | Стартапы года — 2021. Выбор редакции... | Содержание: Qummy OrcaBio Celly.AI ELIQ Maroo Raison Collectly Rarible Mo Tomi.ai Qummy Основатели... | rb.ru/list... |
17.06.2020 | Orca Bio raises $192M in Series D round for effort to replac... | The funding round, which brings the total amount of money Orca has raised to nearly $300 million sin... | medcitynew... |
17.06.2020 | Orca Bio Emerges With Nearly $300 Million to Transform Allog... | Company aims to safely and effectively regenerate a healthy blood and immune system for patients wit... | marketscre... |
- | Orca Bio raises $192M in Series D round for effort to replac... | A company developing allogeneic cell therapies for blood cancers, autoimmune diseases and genetic di... | medcitynew... |